Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cryolife Hydrogel Technology Provides Platform For Diverse Pipeline

This article was originally published in The Gray Sheet

Executive Summary

Atlanta-based Cryolife is preparing for human trials to support approval of its BioDisc spinal disc repair system and plans to file for an FDA investigational device exemption in the first half of 2005

You may also be interested in...



Lumbar Disc Developers Hold Their Own With Orthopedic Giants

Raymedica and Interpore Cross are readying internally-developed artificial spinal disc offerings for U.S. market entry behind J&J/DePuy Acromed, Medtronic/Sofamor Danek and Synthes-Stratec - three companies competing through recent acquisitions

CryoLife Rebuilds Processing Capacity, Eyes Profitability After FDA Reprieve

CryoLife credits San Francisco-based Acumen Sciences for guiding it through an FDA Form 483 and a subsequent recall of cardiac, orthopedic and vascular tissue products

CryoLife SEC Probe Compounds Firm’s Regulatory Woes; FDA Issues Notice

The Securities and Exchange Commission is seeking information from CryoLife on corporate accounting from October 2001 to the present related to a company recall of tissue products, as well as stock trading activity

UsernamePublicRestriction

Register

SC143420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel